Meeting
2023 ASCO Annual Meeting
Sustained organ preservation in rectal cancer patients treated with total neoadjuvant therapy: Long-term results of the OPRA trial.
Authors
Floris S Verheij
Memorial Sloan Kettering Cancer Center, New York, NY
Floris S Verheij , Dana Mohamed Rashid Omer , Hannah Williams , James T Buckley , Sabrina T Lin , Li-Xuan Qin , Hannah M Thompson , Jonathan B Yuval , Marc J Gollub , Abraham Jing-Ching Wu , Leonard B. Saltz , Julio Garcia-Aguilar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
NCT02008656
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3520)
DOI
10.1200/JCO.2023.41.16_suppl.3520
Abstract #
3520
Poster Bd #
220
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy.
First Author: Paul Bernard Romesser
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant oxaliplatin-based therapy (TNT) before (induction) and after (consolidation) chemoradiation for advanced rectal cancer: MRI correlation on complete response and outcome.
First Author: Putao Cen
Poster
2019 Gastrointestinal Cancers Symposium
Temporal trends and disease characteristics associated with total neoadjuvant therapy (TNT) usage.
First Author: Laila Babar
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy.
First Author: Aron Bercz